• Users Online: 255
  • Home
  • Print this page
  • Email this page
Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 108  |  Issue : 4  |  Page : 233-236

Efficacy of topical cyclosporine 0.05% eye drops in the treatment of dry eyes


Department of Ophthalmology, Zagazig Faculty of Medicine, Zagazig, Egypt

Correspondence Address:
Haitham Y Al-Nashar
Department of Ophthalmology, Zagazig Faculty of Medicine, Zagazig
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2090-0686.174683

Rights and Permissions

Purpose The aim of the present study was to evaluate the effectiveness of cyclosporine 0.05% in the treatment of dry-eye disease. Patients and methods A total of 35 eyes of 20 patients with dry-eye disease were included in the present study. Ten patients (20 eyes) had dry eyes associated with systemic rheumatologic disease (Sjögren's syndrome), five patients (10 eyes) had dry eyes after undergoing laser in-situ keratomileusis, and five patients (five eyes) had dry eyes after cataract surgery. Detailed history taking along with full ophthalmic examination was carried out for all patients. In addition, Schirmer's test and break-up time (BUT) test were conducted for all patients. The patients were examined for ocular symptoms of dry eyes (ocular pain, burning, and foreign body sensation). Cyclosporine 0.05% eye drops were prescribed twice daily for 3 months. The patients were followed up after 1, 2, and 3 months. Results In total, 35 eyes of 20 patients diagnosed with dry-eye syndrome were included in this study. The mean age of the patients was 37.3 years (range: 26-65 years).The patients were evaluated for ocular symptoms (burning, pain, and foreign body sensation). Schirmer's paper test and BUT test were conducted for all patients. The score of ocular symptoms before the beginning of the treatment was 2.50 ± 0.46, and this score improved to 0.9 ± 0.52 after 3 months with a statistically significant difference (P = 0.01). Schirmer's paper test was performed before the beginning of the treatment, and showed a wetting of 1.15 ± 0.58 mm of the paper, and improved after 3 months to 5.86 ± 0.29 mm (P = 0.001). BUT improved from 5.57 ± 1.36 s before the treatment to 9.9 ± 0.92 s after 3 months of treatment (P = 0.001). Conclusion Topical cyclosporine 0.05% is effective in the treatment of dry-eye syndrome, which has an inflammatory cause.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6545    
    Printed114    
    Emailed0    
    PDF Downloaded428    
    Comments [Add]    
    Cited by others 4    

Recommend this journal